Abiomed, Inc.ABMDNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P74
Within normal range
vs 2Y Ago
2.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2022 | 94.55% |
| Q2 2022 | -9.57% |
| Q1 2022 | 31.85% |
| Q4 2021 | -19.67% |
| Q3 2021 | 314.71% |
| Q2 2021 | -146.65% |
| Q1 2021 | -8.10% |
| Q4 2020 | -0.55% |
| Q3 2020 | 39.53% |
| Q2 2020 | 40.22% |
| Q1 2020 | -54.06% |
| Q4 2019 | 429.55% |
| Q3 2019 | -85.30% |
| Q2 2019 | 20.23% |
| Q1 2019 | 64.86% |
| Q4 2018 | -10.50% |
| Q3 2018 | -44.34% |
| Q2 2018 | 144.43% |
| Q1 2018 | 174.04% |
| Q4 2017 | -45.13% |
| Q3 2017 | -34.44% |
| Q2 2017 | 150.85% |
| Q1 2017 | -3.45% |
| Q4 2016 | 73.88% |
| Q3 2016 | -31.25% |
| Q2 2016 | 17.38% |
| Q1 2016 | 4.20% |
| Q4 2015 | 36.46% |
| Q3 2015 | -12.69% |
| Q2 2015 | -91.04% |
| Q1 2015 | 679.52% |
| Q4 2014 | 230.40% |
| Q3 2014 | 324.63% |
| Q2 2014 | -147.18% |
| Q1 2014 | -17.55% |
| Q4 2013 | 314.83% |
| Q3 2013 | 161.46% |
| Q2 2013 | -146.04% |
| Q1 2013 | 39.42% |
| Q4 2012 | -50.92% |